Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
1,577,462
-
Share change
-
+3,937
-
Total reported value
-
$1,213,524,580
-
Price per share
-
$771.87
-
Number of holders
-
221
-
Value change
-
+$6,587,129
-
Number of buys
-
120
-
Number of sells
-
69
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2025
As of 31 Dec 2025,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
221 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,577,462 shares.
The largest 10 holders included
Assenagon Asset Management S.A., Aberdeen Group plc, NORDEA INVESTMENT MANAGEMENT AB, SG Americas Securities, LLC, Retirement Systems of Alabama, GuoLine Advisory Pte Ltd, WEDGE CAPITAL MANAGEMENT L L P/NC, Mn Services Vermogensbeheer B.V., Allspring Global Investments Holdings, LLC, and Traynor Capital Management, Inc..
This page lists
221
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.